Ars Live: The rise of GLP-1 drugs: Insights and Unknowns @arstechnica
Ars Live: The rise of GLP-1 drugs: Insights and Unknowns  @arstechnica
Uploaded October 2024 | Updated November 2026, 3 hours ago
Ars Technica Senior Health Reporter Dr. Beth Mole is joined by Dr. Daniel J Drucker, MD, FRCPC from the Lunenfeld Tanenbaum Research Institute for a discussion on the implications, insights, and unknowns around the proliferation and rapid adoption of GLP-1 drugs.
Ars Live: The rise of GLP-1 drugs: Insights and UnknownsTesla Model 3, Mercedes-AMG Project ONE: The best features of the best cars at the L.A. Auto ShowHow MechWarrior 5s Team Fixed Their Player-Killing Level Generator | War Stories | Ars TechnicaXbox One X: Everything you need to know | E3 2017 | Ars TechnicaTeam Xbox on the future of Xbox One X | Ars TechnicaFirst Look: Xbox Adaptive Controller | Ars TechnicaDiablo III and the Best Nintendo Switch Ports | Ars TechnicaArs takes a ride in Jack with Audis piloted driving | Ars TechnicaHow One Gameplay Decision Changed Diablo Forever | War Stories | Ars Technica6 Degrees of Star Control | Ars TechnicaHow The Callisto Protocols Animations Came To Life With Motion Capture | Ars TechnicaHow Crash Bandicoot Hacked The Original Playstation | War Stories | Ars Technica
Ars Technica |

Ars Live: The rise of GLP-1 drugs: Insights and Unknowns

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER